Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-104
Closed -$2K 2487
2023
Q4
$2K Sell
104
-1,901
-95% -$33K ﹤0.01% 3074
2023
Q3
$40K Buy
2,005
+42
+2% +$1.06K ﹤0.01% 1619
2023
Q2
$57K Buy
+1,963
New +$53.8K 0.01% 1217
2022
Q1
Sell
-1,535
Closed -$75.6K 5414
2021
Q4
$117K Buy
1,535
+1,435
+1,435% +$127K ﹤0.01% 1721
2021
Q3
$9K Sell
100
-140
-58% -$15.3K ﹤0.01% 3991
2021
Q2
$25K Buy
240
+100
+71% +$9.84K ﹤0.01% 3102
2021
Q1
$12K Sell
140
-1,450
-91% -$160K ﹤0.01% 3632
2020
Q4
$159K Buy
1,590
+530
+50% +$39.5K 0.01% 1221
2020
Q3
$51K Sell
1,060
-280
-21% -$13.4K ﹤0.01% 1780
2020
Q2
$54K Buy
1,340
+1,040
+347% +$29.9K ﹤0.01% 1686
2020
Q1
$4K Buy
+300
New +$6.3K ﹤0.01% 3164

Other funds holding CRNC

Cutler Group's CRNC Position: Q1 2024 in Review

Cutler Group sold out of Cerence (CRNC) in Q1 2024, closing a stake of 104 shares — an estimated $2K sold.

Cutler Group first reported a position in CRNC in Q1 2020 and held it in 11 quarters. The position peaked at $159K in Q4 2020. 188 funds tracked by Wall St. Rank hold CRNC as of Q1 2024.

  • Cutler Group reported no remaining Cerence position as of Q1 2024 after selling out during the quarter.
  • Cutler Group sold 104 Cerence shares in Q1 2024, an estimated $2K.
  • Cutler Group first reported a position in Cerence in Q1 2020 and held it in 11 quarters.
  • Cutler Group's Cerence position peaked at $159K in Q4 2020.
  • 188 funds tracked by Wall St. Rank held Cerence as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.